首页>
外国专利>
USE OF A HYDROPHILlC MATRIX COMPRISING A POLYACRYLlC ACID DERIVATIVE, A CELLULOSE ETHER AND A DISINTEGRANT FOR THE MANUFACTURE OF A MEDICAMENT FOR TREATING FEMALE GENITAL DISORDERS
USE OF A HYDROPHILlC MATRIX COMPRISING A POLYACRYLlC ACID DERIVATIVE, A CELLULOSE ETHER AND A DISINTEGRANT FOR THE MANUFACTURE OF A MEDICAMENT FOR TREATING FEMALE GENITAL DISORDERS
展开▼
机译:包含聚丙烯酰胺酸衍生物,纤维素醚和崩解剂的亲水基质在制备治疗女性生殖道疾病的药物中的用途
展开▼
页面导航
摘要
著录项
相似文献
摘要
A hydrophilic matrix is disclosed which comprises:a) at least one polyacrylic acid derivative in preferred amounts of 2 - 40%,b) at least one cellulose ether in preferred amounts of 30 - 90% andc) at least one disintegrant in preferred amounts of 2- 50%,with respect to the weight of the matrix.This matrix is used in combination with at least one pharmaceutically acceptable active principle for manufacturing solid bioadhesive controlled release formulations for the treatment of female genital disorders, vaginal disorders, such as vulvovaginal candidiasis, bacterial vaginosis or trichomoniasis, genital hypertrophy, genital atrophy, genital loss of elasticity, vaginal dryness.According to a preferred embodiment, the matrix is used in amounts of about 5 - 60% and the active principle in amounts of about 2- 60%, with respect to the weight of the formulation.
展开▼